Lifeline Skin Care, Inc. is a subsidiary of International Stem Cell Corporation, a publicly traded biotechnology company, founded in 2009. Specializing in health care, biotechnology, wellness, and beauty, Lifeline sets itself apart with its cutting-edge small molecule technology and potent peptides. The company leverages peptides sourced from its human non-embryonic stem cells, combined with proprietary targeted molecule technology, to develop and market advanced cosmetic products. While specific investment details are not available, Lifeline's groundbreaking approach positions it at the forefront of the skincare industry, catering to the ever-growing demand for innovative wellness and beauty solutions.
There is no investment information
No recent news or press coverage available for Lifeline Skin Care, Inc..